SCHEMBL22985877

SCHEMBL22985877

CN1CCN(c2ccc(Nc3nc(N)c(C=N)c(Oc4ccc(NC(=O)CCl)cc4)n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 5/20 0.53
MAP2K1 Q02750 2/20 0.52
EGFR P00533 8/20 0.48
JAK3 P52333 4/20 0.46
JAK2 O60674 2/20 0.46
BLK P51451 1/20 0.46
BMX P51813 1/20 0.46
BTK Q06187 4/20 0.45
KCNH2 Q12809 2/20 0.45
ABCB11 O95342 1/20 0.45
ESR1 P03372 1/20 0.45
CHRM2 P08172 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD1 P21728 1/20 0.45
TBXA2R P21731 1/20 0.45
SLC6A2 P23975 1/20 0.45
PDE4A P27815 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985908 0.88 MAP3K7 (0.69) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018862 0.81 MAP3K7 (0.57) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018787 0.80 MAP3K7 (0.77) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL22985872 0.80 MAP3K7 (0.54) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018907 0.80 MAP3K7 (0.57) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018922 0.80 MAP3K7 (0.59) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL23011296 0.79 MAP3K7 (0.57) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018878 0.72 EGFR (0.79) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018867 0.71 MAP3K7 (0.73) MAP3K7MAP2K1EGFRJAK3JAK2
SCHEMBL18018873 0.71 MAP3K7 (0.68) MAP3K7MAP2K1EGFRJAK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778604-A1 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 EP disclosed
EP-3778605-A2 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 EP disclosed